Search Clinical Trials
589,087 trials
ID
Status
Phase
Title
Sponsor
NCT07644468
Visual Rehabilitation in Children With Autism Spectrum Disorder and Visual DisordersNational Taiwan University HospitalCompletedNot Applicable
NCT07644468Completed
Not Applicable
Visual Rehabilitation in Children With Autism Spectrum Disorder and Visual Disor...National Taiwan Universit...
NCT07646483
Clinical Trial to Evaluate the Efficacy and Safety of Conjuran® After First and Second Cycle (Repeat) Administration in Patients With Knee OsteoarthritisPharmaResearch Co.,LtdNot Yet RecruitingNot Applicable
NCT07646483Not Yet Recruiting
Not Applicable
Clinical Trial to Evaluate the Efficacy and Safety of Conjuran® After First and...PharmaResearch Co.,Ltd
NCT07644130
Bergen Four-Day Treatment (B4DT) for Obsessive-Compulsive DisorderTampere UniversityNot Yet RecruitingNot Applicable
NCT07644130Not Yet Recruiting
Not Applicable
Bergen Four-Day Treatment (B4DT) for Obsessive-Compulsive DisorderTampere University
NCT07643922
Endovascular Therapy for Cerebral Vasospasm After Aneurysmal Subarachnoid HemorrhageBeijing Tiantan HospitalNot Yet RecruitingNot Applicable
NCT07643922Not Yet Recruiting
Not Applicable
Endovascular Therapy for Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorr...Beijing Tiantan Hospital
NCT07646535
A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Primary AldosteronismShenzhen Salubris Pharmaceuticals Co., Ltd.Not Yet RecruitingPhase 2
NCT07646535Not Yet Recruiting
Phase 2
A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses i...Shenzhen Salubris Pharmac...
NCT07644403
Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid Tumors.Suzhou Immunofoco Biotechnology Co., LtdEnrolling By InvitationPhase 1
NCT07644403Enrolling By Invitation
Phase 1
Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid...Suzhou Immunofoco Biotech...
NCT07646314
Comparative Effects of Post-Isometric Relaxation and Reciprocal Inhibition Techniques inPiriformis SyndromeRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07646314Not Yet Recruiting
Not Applicable
Comparative Effects of Post-Isometric Relaxation and Reciprocal Inhibition Techn...Riphah International Univ...
NCT07645495
Frequency Rhythmic Electrical Modulated Stimulation Therapy in Chronic Ulcers.Beni-Suef UniversityNot Yet RecruitingNot Applicable
NCT07645495Not Yet Recruiting
Not Applicable
Frequency Rhythmic Electrical Modulated Stimulation Therapy in Chronic Ulcers.Beni-Suef University
NCT07645443
FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early PsychosisCentral Institute of Mental Health, MannheimRecruitingNot Applicable
NCT07645443Recruiting
Not Applicable
FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adu...Central Institute of Ment...
NCT07645274
Improving Mental Healthcare Outcomes for Minoritized Veterans Through a Peer-led, Patient Navigation Program (PARTNER-MH 2.0)Indiana UniversityNot Yet RecruitingNot Applicable
NCT07645274Not Yet Recruiting
Not Applicable
Improving Mental Healthcare Outcomes for Minoritized Veterans Through a Peer-led...Indiana University
NCT07644312
Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG and DIPGNationwide Children's HospitalNot Yet RecruitingPhase 2
NCT07644312Not Yet Recruiting
Phase 2
Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG...Nationwide Children's Hos...
NCT07645521
Trans-nasal Sphenopalatine Ganglion Block for Prevention of Emergence Agitation Following Functional Endoscopic Sinus SurgeryMansoura UniversityCompletedNot Applicable
NCT07645521Completed
Not Applicable
Trans-nasal Sphenopalatine Ganglion Block for Prevention of Emergence Agitation...Mansoura University
NCT07645118
Brachytherapy Followed by Nivolumab Prior to Surgery in Rectal CancerDr. Te VuongNot Yet RecruitingPhase 2
NCT07645118Not Yet Recruiting
Phase 2
Brachytherapy Followed by Nivolumab Prior to Surgery in Rectal CancerDr. Te Vuong
NCT07644416
Using Virtual Reality Travel to Reduce Loneliness in Older AdultsIndiana UniversityNot Yet RecruitingNot Applicable
NCT07644416Not Yet Recruiting
Not Applicable
Using Virtual Reality Travel to Reduce Loneliness in Older AdultsIndiana University
NCT07643935
Prognostic Value of 177Lutetium-PSMA Single Photon Emission Tomography and Timing of ResponseCentral Hospital, Nancy, FranceNot Yet Recruiting
NCT07643935Not Yet Recruiting
—
Prognostic Value of 177Lutetium-PSMA Single Photon Emission Tomography and Timin...Central Hospital, Nancy,...
NCT07644624
Sling vs. Dynamic Shoulder Stabilizer After Soft Tissue Shoulder Instability Surgery (SLIDY)Hospital Universitari de BellvitgeNot Yet RecruitingNot Applicable
NCT07644624Not Yet Recruiting
Not Applicable
Sling vs. Dynamic Shoulder Stabilizer After Soft Tissue Shoulder Instability Sur...Hospital Universitari de...
NCT07645170
Strain Counter-Strain vs Maitland Mobilization for Sacroiliac Joint PainUniversity of FaisalabadActive Not RecruitingNot Applicable
NCT07645170Active Not Recruiting
Not Applicable
Strain Counter-Strain vs Maitland Mobilization for Sacroiliac Joint PainUniversity of Faisalabad
NCT07646171
EVERST- Everolimus After Alpelisib in Women With Hormone Receptor-positive (HR+) Metastatic Breast Cancer (MBC)Tel-Aviv Sourasky Medical CenterRecruiting
NCT07646171Recruiting
—
EVERST- Everolimus After Alpelisib in Women With Hormone Receptor-positive (HR+)...Tel-Aviv Sourasky Medical...
NCT07645417
Maxillary Canine Retraction Using Stainless Steel and Titanium-molybdenum Alloy Wires in TAD-supported Segmental MechanicsTanzila RafiqueEnrolling By InvitationNot Applicable
NCT07645417Enrolling By Invitation
Not Applicable
Maxillary Canine Retraction Using Stainless Steel and Titanium-molybdenum Alloy...Tanzila Rafique
Result Breakdown
Not yet recruiting13 (65%)
Completed2 (10%)
Enrolling by invitation2 (10%)
Recruiting2 (10%)
Active, not recruiting1 (5%)
not_applicable13 (65%)
Phase 23 (15%)
Phase 12 (10%)
Not Specified2 (10%)